Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) (TEPTAU)

Trial Profile

Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) (TEPTAU)

Phase of Trial: Phase II

Latest Information Update: 12 Feb 2019

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Acronyms TEPTAU
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 20 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 23 Jan 2017 Planned initiation date changed from 1 Feb 2017 to 23 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top